Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J O Liliemark

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Research|March 1, 1986
Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphateJ O Liliemark, W Plunkett
Cancer Research|November 1, 1985
Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosineJ O Liliemark, W Plunkett, D O Dixon
Leukemia & Lymphoma|October 1, 1996
Why do drugs work in CLL?W Plunkett, A Begleiter, J O Liliemark, et al.
Seminars in Oncology|June 1, 1987
Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-CW Plunkett, J O Liliemark, E Estey, et al.
Seminars in Oncology|June 1, 1987
ara-C in plasma and ara-CTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of ara-C in patients with acute nonlymphoblastic leukemiaJ O Liliemark, G Gahrton, C Y Paul, et al.
Cancer Research|May 1, 1985
Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic cells after intravenous and subcutaneous administration of 1-beta-D-arabinofuranosylcytosineJ O Liliemark, C Y Paul, C G Gahrton, et al.
Seminars in Oncology|June 1, 1985
Pharmacologically directed ara-C therapy for refractory leukemiaW Plunkett, S Iacoboni, E Estey, et al.
Therapeutic Drug Monitoring|September 1, 1987
Comparison of the pharmacokinetics of AMSA and AMSA-lactate in patients with acute nonlymphoblastic leukemiaC Y Paul, J O Liliemark, R H Farmen, et al.
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Research|March 1, 1986
Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphateJ O Liliemark, W Plunkett
Cancer Research|November 1, 1985
Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosineJ O Liliemark, W Plunkett, D O Dixon
Leukemia & Lymphoma|October 1, 1996
Why do drugs work in CLL?W Plunkett, A Begleiter, J O Liliemark, et al.
Seminars in Oncology|June 1, 1987
Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-CW Plunkett, J O Liliemark, E Estey, et al.
Seminars in Oncology|June 1, 1987
ara-C in plasma and ara-CTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of ara-C in patients with acute nonlymphoblastic leukemiaJ O Liliemark, G Gahrton, C Y Paul, et al.
Cancer Research|May 1, 1985
Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic cells after intravenous and subcutaneous administration of 1-beta-D-arabinofuranosylcytosineJ O Liliemark, C Y Paul, C G Gahrton, et al.
Seminars in Oncology|June 1, 1985
Pharmacologically directed ara-C therapy for refractory leukemiaW Plunkett, S Iacoboni, E Estey, et al.
Therapeutic Drug Monitoring|September 1, 1987
Comparison of the pharmacokinetics of AMSA and AMSA-lactate in patients with acute nonlymphoblastic leukemiaC Y Paul, J O Liliemark, R H Farmen, et al.
Cancer Research|June 1, 1987
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapyW Plunkett, J O Liliemark, T M Adams, et al.
Pageof 1